Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2004 September; 5(3): 23–29.
Published online 2004 June 4. doi:  10.1208/pt050339
PMCID: PMC2750262

In vitro evaluation of a morphine polymeric complex: Flowability behavior and dissolution study


The purpose of this research was to perform a granulometrical and flow properties study of a morphine polymeric complex and determine the influence of 3 variables—particle size of complex, pH value, and ionic strength of the dissolution medium—on the dissolution behavior. The morphine-Eudragit L complex was produced in aqueous medium from morphine hydrochloride saturated solution and Eudragit L 30D diluted until 12% wt/vol and partially neutralized (40%). To determine the rheological behavior of the complex, several rheological tests were developed: bulk and tapped densities, Hausner ratio, angle of repose, and flow rate. The results corresponding to the technological study suggest that the 100- to 250-μm fraction can be considered as free flowing powder. In relation to the dissolution behavior of the complex, the results indicate that the ionic strength has been detected as the most influencing factor when values below physiological conditions are used. In conclusion, no technological problems for the production of further solid dosage forms are expected. Furthermore, no changes in the dissolution profiles of the complex have been detected when ionic strength values are inside the physiological range.

Keywords: morphine-Eudragit complex, rheology, dissolution medium, dissolution medium, pH

Full Text

The Full Text of this article is available as a PDF (193K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Cancer Pain Relief. Geneva, Switzerland: WHO; 1986.
2. Rabasco AM, Fernández-Arévalo M, Alvarez-Fuentes J, Holgado MA, Caraballo I, inventors. Sistema de liberación controlada de morfina y otros fármacos solubles en agua por complejación con sustancias poliméricas. Spanish patent P9401748. August 1, 1994.
3. Alvarez-Fuentes J, Fernández-Arévalo M, Holgado MA, Caraballo I, Llera JM, Rabasco AM. Morphine polymeric coprecipitates for controlled release: elaboration and characterization. Drug Dev Ind Pharm. 1994;20:2409–2424. doi: 10.3109/03639049409042646. [Cross Ref]
4. Alvarez-Fuentes J, Fernández-Arévalo M, Holgado MA, Caraballo I, Llera JM, Rabasco AM. Characterization of morphine polymeric coprecipitates: a biopharmaceutical study. Pharmazie. 1994;49:834–839.
5. Alvarez-Fuentes J, Holgado MA, Caraballo I, Fernández-Arévalo M, Rabasco AM. Influence of the pH value of the dissolution medium on the release profiles of a morphine polymeric complex. Drug Dev Ind Pharm. 1997;23:553–559. doi: 10.3109/03639049709149819. [Cross Ref]
6. Alvarez-Fuentes J, Fernández-Arévalo M, Holgado MA, et al. Preclinical study of a controlled release oral morphine system in rats. Int J Pharm. 1996;139:237–241. doi: 10.1016/0378-5173(96)04612-1. [Cross Ref]
7. Fernández-Arévalo M, Caraballo I, Millán M, et al. Optimisation of a complexation process as a new method for obtaining a controlled morphine delivery system. STP Pharma Sci. 2002;12:334–336.
8. Real Farmacopea Española. 2nd ed. Ministerio de Sanidady Consumo: Madrid, Spain; 2002.
9. Iruin A, Alvarez Fuentes J, Holgado MA, Fernández Arévalo M. Influence of particle size of morphine polymeric complex over the release behavior of tablets. Paper presented at: European Conference on Drug Delivery and Pharmaceutical Technology; May 10–12, 2004; Sevilla, Spain.
10. Lin Ju H, Liaw SJ. On the assessment of similarity of drug dissolution profiles: a simulation study. Drug Inf J. 1997;31:1273–1289.
11. Lindhal A, Ungell AL, Knutson L, Lennernas H. Characterization of fluids from the stomach and proximal jejunum in men and women. Pharm Res. 1997;14:497–502. doi: 10.1023/A:1012107801889. [PubMed] [Cross Ref]
12. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25–35. doi: 10.1016/0378-5173(83)90064-9. [Cross Ref]
13. Bonferoni MC, Rossi S, Ferrari F, Stavik E, Peña-Romero A. Caramella C. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes. AAPS PharmSciTech. 2000;1(2):E15–E15. doi: 10.1208/pt010215. [PMC free article] [PubMed] [Cross Ref]
14. Mu X, Tobyn MJ, Staniforth JN. Influence of physiological variables on the in vitro drug release behavior of a polysaccharide matrix controlled-release system. Drug Dev Ind Pharm. 2003;29:19–29. doi: 10.1081/DDC-120016680. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists